BRAF V600 mutations and pathological features in Japanese melanoma

被引：0
|
作者：
Yamazaki, N. [1 ]
Tanaka, R. [1 ]
Tsutsumida, A. [1 ]
Namikawa, K. [1 ]
Eguchi, H. [1 ]
Omata, W. [1 ]
Oashi, K. [1 ]
Tsuta, K. [2 ]
机构：
[1] Natl Canc Ctr, Chuo Ku, Tokyo, Japan
[2] Natl Canc Ctr, Pathol & Clin Labs, Chuo Ku, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3758
引用
收藏
页码：S874 / S874
页数：1
相关论文
共 50 条
  • [1] BRAF V600 mutations and pathological features in Japanese melanoma patients
    Yamazaki, Naoya
    Tanaka, Ryota
    Tsutsumida, Arata
    Namikawa, Kenjiro
    Eguchi, Hironobu
    Omata, Wataru
    Oashi, Kohei
    Ogawa, Toru
    Hayashi, Amiko
    Nakamura, Noriyuki
    Tsuta, Koji
    MELANOMA RESEARCH, 2015, 25 (01) : 9 - 14
  • [2] Melanoma Effectiveness of Vemurafenib on BRAF V600 Mutations
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2014, 40 (11) : 434 - 434
  • [3] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [4] THE COST OF STAGE IV MELANOMA WITH BRAF V600 MUTATIONS IN GREECE
    Carayanni, V
    Gogas, H.
    Bafaloukos, D.
    Boukovinas, I
    Latsou, D.
    Stamuli, E.
    Hatzikou, M.
    VALUE IN HEALTH, 2020, 23 : S462 - S462
  • [5] BRAF V600 Mutation in Malignant Melanoma
    Czirbesz, K.
    Plotar, V
    Serester, O.
    Liszkay, G.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 44 - 45
  • [6] The role of BRAF V600 mutation in melanoma
    Paolo A Ascierto
    John M Kirkwood
    Jean-Jacques Grob
    Ester Simeone
    Antonio M Grimaldi
    Michele Maio
    Giuseppe Palmieri
    Alessandro Testori
    Francesco M Marincola
    Nicola Mozzillo
    Journal of Translational Medicine, 10
  • [7] The role of BRAF V600 mutation in melanoma
    Ascierto, Paolo A.
    Kirkwood, John M.
    Grob, Jean-Jacques
    Simeone, Ester
    Grimaldi, Antonio M.
    Maio, Michele
    Palmieri, Giuseppe
    Testori, Alessandro
    Marincola, Francesco M.
    Mozzillo, Nicola
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [8] BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer
    Gao, Y.
    Chang, R.
    Huan, J.
    Xiao, X.
    Liu, Y.
    Zhou, Y.
    Li, L.
    Cheng, Y.
    Zhang, C.
    Dai, P.
    Guan, Y.
    Yi, X.
    Xia, X.
    Yang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S911 - S911
  • [9] Targeted Therapy for Melanomas Without BRAF V600 Mutations
    Christian Menzer
    Jessica C. Hassel
    Current Treatment Options in Oncology, 2022, 23 : 831 - 842
  • [10] A Sensitive Peptide Nucleic Acid Probe Assay for Detection of BRAF V600 Mutations in Melanoma
    Chen, Tai-Long
    Chang, John Wen-Cheng
    Hsieh, Jia-Juan
    Cheng, Hsin-Yi
    Chiou, Chiuan-Chian
    CANCER GENOMICS & PROTEOMICS, 2016, 13 (05) : 381 - 386
12345